首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
【24h】

Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.

机译:用于测定胍基化合物的自动化系统,以评估尿毒症状态和血液透析效果。

获取原文
获取原文并翻译 | 示例
       

摘要

An automated HPLC system coupled with fluorometry was established for the sensitive, rapid, and accurate assay of serum guanidines. Naturally fluorescent materials characteristic of the sera of uremic patients (uremic fluorescences) which interfere with the assay were removed simultaneously with deproteinization. Application of this method revealed that the uremic patients who are capable of excreting urine under hemodialysis therapy show low serum guanidinosuccinic acid levels. The interval between hemodialysis sessions in one of these patients was prolonged while monitoring guanidinosuccinic acid level using the present method without any hazardous effect.
机译:建立了结合荧光法的自动HPLC系统,用于灵敏,快速,准确地测定血清胍。在去除蛋白质的同时,去除了干扰尿液检测的尿毒症患者血清的自然荧光物质(尿毒症荧光)。该方法的应用表明,在血液透析治疗下能够排尿的尿毒症患者血清胍基琥珀酸水平较低。使用本方法监测胍基琥珀酸水平时,延长了其中一名患者的血液透析时间间隔,而没有任何有害影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号